Friday, January 27, 2017

BRIEF-Vicore pharma receives orphan drug designation from FDA for treatment of IPF

* Has been granted orphan drug designation from FDA for

treatment of IPF

Source text for Eikon:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)